Rigel Pharmaceuticals Inc.

RIGL Nasdaq SEC CIK 1034842
Follow Rigel Pharmaceuticals Weekly email: filings, results

Financials

Reported figures only · latest: Q3 2026 USD · US GAAP
Revenue, last quarter $80.9M +16.5% vs same quarter last year
Net income $13.2M −52.7% vs same quarter last year
EPS, diluted $0.65 −55.5% vs same quarter last year
Operating cash flow $34.6M +43.8% vs same quarter last year
Revenue by quarter
$57.6M
$53.3M
$101.7M
$69.5M
$69.8M
$58.8M
$78.7M
$80.9M
Q4 24 Q1 25 Q2 25 Q3 25 Q4 25 Q1 26 Q2 26 Q3 26

Source: SEC XBRL filings · latest filing

The long view

Fiscal years as reported · SEC XBRL filings, US GAAP
Revenue and net income15 fiscal years
  • Revenue
  • Net income
−$200M$0$200M$400MFY11FY13FY15FY17FY19FY21FY23FY25
Show the numbers
YearRevenueNet income
FY25$294.3M$367M
FY24$179.3M$17.5M
FY23$116.9M−$25.1M
FY22$120.2M−$58.6M
FY21$149.2M−$17.9M
FY20$108.6M−$29.7M
FY19$59.3M−$66.9M
FY18$44.5M−$70.5M
FY17$4.5M−$78M
FY16$20.4M−$69.2M
FY15-−$51.5M
FY14-−$90.9M
FY13-−$89M
FY12-−$98.8M
FY11-−$86M
MarginsShare of revenue
  • Gross margin
  • Operating margin
  • Net margin
−2000%−1500%−1000%−500%0%500%FY11FY13FY15FY17FY19FY21FY23FY25
Show the numbers
YearGross marginOperating marginNet margin
FY2593.3%42.6%124.7%
FY2489.6%13.5%9.8%
FY2393.9%−17.5%−21.5%
FY2298.5%−46.2%−48.7%
FY2199.3%−8.4%−12%
FY2099.2%−26.7%−27.4%
FY1998.5%−116.5%−112.8%
FY1899.4%−163.3%−158.3%
FY17-−1775.6%−1739.3%
FY16-−342.2%−339.6%
FY15---
FY14---
FY13---
FY12---
FY11---
Free cash flowOperating cash flow minus capital expenditure
−$100M−$75M−$50M−$25M$0$25MFY11FY13FY15FY17FY19FY21FY23FY25
Show the numbers
YearFree cash flow
FY25-
FY24-
FY23-
FY22−$74.2M
FY21$5.3M
FY20−$53.4M
FY19−$43M
FY18−$59.9M
FY17−$77.7M
FY16−$76.7M
FY15−$24M
FY14−$70.2M
FY13−$87.3M
FY12−$88.6M
FY11−$71.7M
Net margin vs the sectorMedian of Healthcare companies filing with the SEC
  • Rigel Pharmaceuticals
  • Healthcare median
−2000%−1500%−1000%−500%0%500%FY11FY13FY15FY17FY19FY21FY23FY25
Show the numbers
YearRigel PharmaceuticalsHealthcare median
FY25124.7%−30.6%
FY249.8%−47%
FY23−21.5%−58%
FY22−48.7%−80.4%
FY21−12%−71.8%
FY20−27.4%−62.2%
FY19−112.8%−46.2%
FY18−158.3%−49.6%
FY17−1739.3%−45.9%
FY16−339.6%−36%
FY15-−37.8%
FY14-−35.5%
FY13-−37.1%
FY12-−29.1%
FY11-−27.9%